Addressing the problem of ADHD medication as neuroenhancements

References

• CDC. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 2010;59(44):1439-43
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Mental health surveillance among children-United States, 2005–2011. US Dept of Health and Human Services; Atlanta, GA, USA: 2013
   Google Scholar
• Zuvekas SH, Vitiello B. Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 2012;169(2):160-6
   PubMed Web of Science ®Google Scholar
• International Narcotics Control Board (INCB). Report of the International Narcotics Control Board for 2012. United Nations ISBN: 978-92-1-148270-6; Vienna, Austria: 2013
   Google Scholar
• Mayes R, Bagwell C, Erkulwater J. ADHD and the rise in stimulant use among children. Harv Rev Psychiatry 2008;16:151-66
   PubMed Web of Science ®Google Scholar
• Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 2003;42:1203-11
   PubMed Web of Science ®Google Scholar
• Visser SN, Danielson ML, Bitsko RH, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention deficit/hyperactivity disorder: United States, 2003–2011. J Am Acad Child Adol Psych 2014;53(1):34-46; e2
   PubMed Web of Science ®Google Scholar
• Express Scripts. Turning attention to ADHD: U.S. medication trends for attention deficit hyperactivity disorder. Express Scripts; Louis, MO, USA: 2014
   Google Scholar
• Merikangas KR, He JP, Rapoport J, et al. Medication use in US youth with mental disorders. JAMA Pediatr 2013;167(2):141-8
   PubMed Web of Science ®Google Scholar
• Barbaresi WJ, Colligan RC, Weaver AL, et al. Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics 2013;131(4):1-8
   PubMed Web of Science ®Google Scholar
• Thomas R, Mitchell GK, Batstra L. Attention-deficit/hyperactivity disorder: are we helping or harming? BMJ 2013;347:f6172
   PubMed Web of Science ®Google Scholar
• LeFever GB, Arcona AP, Antonuccio DO. ADHD among American schoolchildren: evidence of overdiagnosis and overuse of medication. Sci Rev Ment Health Pract 2003;2:49-60
   Google Scholar
• Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Attention Dis 2007;11(2):106-13
   PubMedGoogle Scholar
• Singh I, Kelleher KJ. Neuroenhancement in young people: proposal for research, policy and clinical management. Am J Bioethics Neurosci 2010;1(1):3-16
   PubMedGoogle Scholar
• Rasmussen N. America’s first amphetamine epidemic 1929-1971: a quantitative and qualitative retrospective with implications for the present. Am J Public Health 2008;98(6):974-85
   PubMed Web of Science ®Google Scholar
• Hinshaw SP, Scheffler RM. The ADHD explosion: myths, medication, money, and today’s push for performance. Oxford University Press; NY, USA: 2014
   Google Scholar
• Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. Edition 3. Guilford Press; Guilford, NY, USA: 2006
   Google Scholar
• Sahakian B, Morein-Zamir S. Professor’s little helper. Nature 2007;450:1157-9
   PubMed Web of Science ®Google Scholar
• Smith ME, Farah MJ. Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 2011;137(5):717-41
   PubMed Web of Science ®Google Scholar
• Miller G. Pediatric bioethics. Cambridge University Press; NY, USA: 2009
   Google Scholar
• Nagel SK. Ethics and the neurosciences. Ethical and social consequences of neuroscientific progress. Paderborn; Germany, Mentis: 2010
   Google Scholar
• Kinsbourne M, Graf WD. Disorders of mental development. In: Menkes JH, Sarnat HB, editors. Child neurology. 6th edition. Lippincott Williams & Wilkins; PA, USA: 2000. p. 1155-211
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental health disorders: DSM-5. 5th edition. American Psychiatric Publishing; Washington, DC ,USA: 2013
   Google Scholar
• Wing L. The definition and prevalence of autism: a review. Eur Child Adolesc Psychiatry 1993;2:61-74
   PubMedGoogle Scholar
• Blumberg SJ, Bramlett MD, Kogan MD, et al. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011–2012. Centers for Disease Control and Prevention’s National Center for Health Statistics; Atlanta, GA, USA: 2013
   Google Scholar
• Poultney CS, Goldberg AP, Drapeau E, et al. Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. Am J Hum Genet 2013;93(4):607-19
   PubMed Web of Science ®Google Scholar
• Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and Autism. N Engl J Med 2012;366:733-43
   PubMed Web of Science ®Google Scholar
• Döpfner M, Breuer D, Wille N, The BELLA Study Group. How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder? Parent-based prevalence rates in a national sample – results of the BELLA study. Eur Child Adolesc Psychiatry 2008;17:59-70
   PubMed Web of Science ®Google Scholar
• Swanson JM, Wigal T, Lakes K, Volkow ND. ADHD: defining a spectrum disorder and considering neuroethical implications. In: Illes J, Sahakian BJ, editors. The oxford handbook of neuroethics. Oxford University Press; NY, USA: 2011. p. 309-39
   Google Scholar
• Parens E, Johnson J. Facts, values and attention deficit hyperactivity disorder (ADHD): an update on the controversies. Child Adolesc Psychiatry Ment Health 2009;3:1
   PubMedGoogle Scholar
• Scheffler RM, Hinshaw SP, Modrek S, Levine P. The global market for ADHD medications. Health Aff (Millwood) 2007;26:450-7
   PubMed Web of Science ®Google Scholar
• Morgan PL, Staff J, Hillemeier MM, et al. Diagnosis from kindergarten to eighth grade. Pediatrics 2013;132(1):85-93
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8
   PubMed Web of Science ®Google Scholar
• Singh I, Filipe AM, Bard I, et al. Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians. Curr Psychiatry Rep 2013;15(9):385
   PubMed Web of Science ®Google Scholar
• Schlack R, Hölling H, Kurth B-M, Huss M. Die Prävalenz der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Kindern und Jugendlichen in Deutschland. Erste Ergebnisse aus dem Kinder und Jugendgesundheitssurvey (KiGGS). Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2007;50:827-35
   PubMed Web of Science ®Google Scholar
• Franke AG, Papenburg C, Schotten E, et al. Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany. BMC Fam Pract 2014;15:3
   PubMed Web of Science ®Google Scholar
• Hodgkins P, Sasané R, Meijer WM. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther 2011;33(2):188-203
   PubMed Web of Science ®Google Scholar
• Sattler S, Sauer C, Mehlkop G, Graeff P. The rationale for consuming cognitive enhancement drugs in university students and teachers. PLoS One 2013;8(7):e68821
   Google Scholar
• Hinshaw SP, Scheffler RM, Fulton BD, et al. International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv 2011;62(5):459-64
   PubMed Web of Science ®Google Scholar
• Swanson JM, Wigal TL, Volkow ND. Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction: comment on Smith and Farah. Psychol Bull 2011;137(5):742-8
   PubMed Web of Science ®Google Scholar
• Burt SA. Rethinking environmental contributions to child and adolescent psychopathology: a meta-analysis of shared environmental influences. Psychol Bull 2009;135:608-37
   PubMed Web of Science ®Google Scholar
• Franke B, Faraone SV, Asherson P, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry 2012;17:960-87
   PubMed Web of Science ®Google Scholar
• Morrow RL, Garland EJ, Wright JM, et al. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ 2012;184(7):755-62
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics: subcommittee on attention-deficit/hyperactivity disorder and committee on quality improvement. clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:1033-44
   PubMed Web of Science ®Google Scholar
• American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry; Washington, DC, USA: 2007
   Google Scholar
• American Psychological Association, APA Working Group on Psychoactive Medications for Children and Adolescents. Report of the working group on psychoactive medications for children and adolescents: psychopharmacological, psychosocial, and combined interventions for childhood disorders: evidence base, contextual factors, and future directions. American Psychological Association; Washington, DC, USA: 2006
   Google Scholar
• Ponneta K, Woutersa E, Van Halc G, et al. Determinants of physicians’ prescribing behaviour of methylphenidate for cognitive enhancement. Psychol Health Med 2014;19(3):286-95
   PubMed Web of Science ®Google Scholar
• Caruso D. Autism in the U.S.: social movement and legal change. Am J Law Med 2010;36(4):483-539
   PubMed Web of Science ®Google Scholar
• Maglione MA, Gan sD, Das L, Technical Expert Panel. et al. Nonmedical interventions for children with ASD: recommended guidelines and further research needs. Pediatrics 2012;130(Suppl 2):S169-78
   PubMedGoogle Scholar
• American Academy of Pediatrics. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:1007-22
   PubMed Web of Science ®Google Scholar
• Schwarz A. Attention disorder or not, pills to help in school. Available from: www.nytimes.com/2012/10/09/health/attention-disorder-or-not-children-prescribed-pills-to-help-in-school.html?pagewanted=all&_r=0; [Last accessed 9 October 2012]
   Google Scholar
• National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. NICE clinical guideline. 2013. [ Epub ahead of print]
   Google Scholar
• Frances C, Hoizey G, Millart H, Trenque T. Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France. Br J Clin Pharmacol 2004;57(1):115-16
   PubMed Web of Science ®Google Scholar
• Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics 2004;114(5):e541-7
   PubMed Web of Science ®Google Scholar
• Langberg JM, Vaughn AJ, Brinkman WB, et al. Clinical utility of the Vanderbilt ADHD Rating Scale for ruling out comorbid learning disorders. Pediatrics 2010;126(5):e1033-8
   Web of Science ®Google Scholar
• Kaye S, Darke S. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction 2012;107(3):467-77
   PubMed Web of Science ®Google Scholar
• Sollman MJ, Ranseen JD, Berry TR. Detection of feigned ADHD in College Students. Psychol Assess 2010;22(2):325-35
   PubMed Web of Science ®Google Scholar
• Jasinski LJ, Harp JP, Berry DTR, et al. Using symptom validity tests to detect malingered ADHD in college students. Clin Neuropsychol 2011;25(8):1415-28
   PubMed Web of Science ®Google Scholar
• Conrad P. The Medicalization of Society: On the transformation of human conditions into treatable disorders. Johns Hopkins Press; Baltimore, MD, USA: 2007
   Google Scholar
• Szasz TS. The medicalization of everyday life: selected essays. Syracuse University Press; NY, USA: 2007
   Google Scholar
• Parens E. On good and bad forms of medicalization. Bioethics 2011. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Nissen SE. ADHD drugs and cardiovascular risk. N Engl J Med 2006;354(14):1445-8
   PubMed Web of Science ®Google Scholar
• Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2006;163(7):1149-52
   PubMed Web of Science ®Google Scholar
• Schelleman H, Bilker WB, Kimmel SE, et al. Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry 2012;169:178-85
   PubMed Web of Science ®Google Scholar
• Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011;365(20):1896-904
   PubMed Web of Science ®Google Scholar
• Substance abuse and mental health services administration center for behavioral health statistics and quality. The DAWN report: update on emergency department visits involving energy drinks: a continuing public health concern. Rockville, MD, USA: 2013
   Google Scholar
• Swanson JM, Volkow ND. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 2003;27:615-21
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001;21RC121:1-5
   Google Scholar
• Kim Y, Merilee A, Teylan MA, et al. Methylphenidate-induced dendritic spine formation and delta FosB expression in nucleus accumbens. PNAS 2009;106(8):2915-20
   PubMed Web of Science ®Google Scholar
• Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 2010;62(3):187-210
   PubMed Web of Science ®Google Scholar
• Turner DC, Robbins TW, Clark L, et al. Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology (Berl) 2003;168:455-64
   PubMed Web of Science ®Google Scholar
• Rogers RD, Blackshaw AJ, Middleton HC, et al. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacol (Berl) 1999;146(4):482-91
   PubMed Web of Science ®Google Scholar
• Sharpe K. The smart-pill oversell. Evidence is mounting that medication for ADHD doesn’t make a lasting difference to schoolwork or achievement. Nature 2014;506:146-8
   PubMed Web of Science ®Google Scholar
• Ilieva I, Boland J, Farah MJ. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology 2013;64:496-505
   PubMed Web of Science ®Google Scholar
• McCabe SE, West BT, Cranford JA, et al. Medical misuse of controlled medications among adolescents. Arch Pediatr Adolesc Med 2011;165(8):729-35
   PubMed Web of Science ®Google Scholar
• Rabiner DL. Stimulant prescription cautions: addressing misuse, diversion and malingering. Curr Psychiatry Rep 2013;15(7):1-8
   Web of Science ®Google Scholar
• Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975-2008. Volume I: Secondary school students (NIH Publication No. 09-7402). National Institute on Drug Abuse; Bethesda, MD, USA: 2009
   Google Scholar
• O’Leary JC. An analysis of the legal issue surrounding the forced use of Ritalin: protecting a child’s right to ‘just say no’. New Engl Law Rev 1993;27:1173-209
   PubMedGoogle Scholar
• McCabe SE, West BT, Teter CJ, et al. Characteristics associated with the diversion of controlled medications among adolescents. Drug Alcohol Depend 2011;118(2-3):452-8
   PubMed Web of Science ®Google Scholar
• Larriviere D, Williams MA, Rizzo M, Bonnie RJ, and the AAN Ethics Law and Humanities Committee. Responding to requests from adult patients for neuorenhancemnts. Guidance of the Ethics, Law and Humanities Committee. Neurology 2009;73:1406-12
   PubMed Web of Science ®Google Scholar
• Illes J, Sahakian B. The Oxford handbook of neuroethics. Oxford University Press; NY, USA: 2011
   Google Scholar
• Schermer M. I., Bolt R, de Jongh B, Olivier B. The future of psychopharmacological enhancement: expectations and policies. Neuroethics 2009;2:74-87
   Web of Science ®Google Scholar
• Buchanan A. Beyond humanity? The ethics of biomedical enhancement. Oxford University Press; Oxford, UK: 2011
   Google Scholar
• Glannon W. Psychopharmacological enhancement. Neuroethics 2008;1:45-54
   Web of Science ®Google Scholar
• Outram SM. Ethical considerations in the framing of the cognitive enhancement Debate. Neuroethics 2012;2:172-84
   Google Scholar
• Harris J. Enhancing evolution. The ethical case for making better people. Princeton University Press; Oxford, UK: 2007
   Google Scholar
• Savulescu J, Bostrom N. Enhancement of human beings. Oxford University Press; Oxford, UK: 2009
   Google Scholar
• Parens E. Enhancing human traits: ethical and social implications. Georgetown University Press; Washington, DC, USA: 1998
   Google Scholar
• Levy N. Neuroethics: challenges for the 21st century. Cambridge University Press; Cambridge, UK: 2007
   Google Scholar
• Graf WD, Nagel SK, Epstein LG, et al. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications. Neurology 2013;80(13):1251-60
   PubMed Web of Science ®Google Scholar
• Beauchamp TL, Childress JF. Principles of biomedical ethics. 6th edition. Oxford University Press; NY, USA; 2008.
   Google Scholar
• American Academy of Pediatrics Committee on Bioethics. Informed consent, parental permission, and assent in pediatric practice. Pediatrics 1995;95:314-17
   PubMed Web of Science ®Google Scholar
• Dworkin G. The theory and practice of autonomy. Cambridge University Press; NY, USA: 1988
   Google Scholar
• King NMP, Cross AW. Children as decision makers: guidelines for pediatricians. J Pediatr 1989;115(1):10-16
   PubMed Web of Science ®Google Scholar
• Nagel SK. Autonomy - a genuinely gradual phenomenon. Am J Bioethics Neurosci 2013;4(4):60-1
   Google Scholar
• Berlan ED, Bravendar T. Confidentiality, consent and caring for the adolescent population. Curr Opin Pediatr 2009;21:450-6
   PubMed Web of Science ®Google Scholar
• Weithorn LA, Campbell SB. The competency of children and adolescents to make informed treatment decisions. Child Dev 1982;53(6):1589-98
   PubMed Web of Science ®Google Scholar
• Unguru Y, Coppes MJ, Kamani N. Rethinking pediatric assent: from requirement to ideal. Pediatr Clin North Am 2008;55(1):211-22
   PubMed Web of Science ®Google Scholar
• Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008;456:702-5
   PubMed Web of Science ®Google Scholar
• Rosenthal MB, Berndt ER, Donohue JM, et al. Promotion of prescription drugs to consumers. N Engl J Med 2002;346:498-505
   PubMed Web of Science ®Google Scholar
• Berndt ER. To inform or persuade? Direct-to-consumer advertising of prescription drugs. N Engl J Med 2005;352(4):325-8
   PubMed Web of Science ®Google Scholar
• Friedman M, Gould J. Consumer attitudes and behaviors associated with direct-to-consumer prescription drug marketing. J Consum Market 2007;24(2):100-9
   Google Scholar
• Mintzes B, Barer ML, Kravitz RL, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 2003;169(5):405-12
   PubMed Web of Science ®Google Scholar
• McCullough LB. Contributions of ethical theory to pediatric ethics: pediatricians and parents as co-fiduciaries of pediatric patients. In: Miller G, editor. Pediatric bioethics. Cambridge University Press; NY, USA: 2010. p. 11-21
   Google Scholar
• Farah MJ, Gillihan SJ. The puzzle of neuroimaging and psychiatric diagnosis: technology and nosology in an evolving discipline. AJOB Neurosci 2012;3(4):31-41
   PubMedGoogle Scholar